Literature DB >> 3553965

The role of cytoplasmic (newly synthesized) dopamine for the spontaneous and electrically evoked release of dopamine and its metabolites from the isolated neurointermediate lobe of the rat pituitary gland in vitro.

K Racké, E Böhm, E Muscholl.   

Abstract

Isolated rat NILs were incubated in Krebs-HEPES solution. The release of dopamine and its metabolites (DOPAC, HVA and MOPET) was determined by HPLC with electrochemical detection. The spontaneous release of the sum of metabolites was about 40 times that of dopamine. The spontaneous outflow of dopamine metabolites was unaffected after inhibition of dopamine uptake (by GBR 12921) or after pretreatment with reserpine (5 mg/kg, 12 h before the experiments), but it was reduced by 50% after preincubation with the irreversible DOPA decarboxylase inhibitor, (MFMD, 10 microM, for 10 min). The combination of pretreatment with reserpine and preincubation with MFMD resulted in an 80% inhibition of the spontaneous outflow of dopamine metabolites. Treatment with reserpine caused a 98% depletion of the dopamine tissue content, whereas 60 min after exposure to MFMD the dopamine tissue content was decreased by 40%. Electrical stimulation of the pituitary stalk (3-15 Hz, in the presence of GBR 12921) caused a frequency-dependent release of dopamine. Stimulation at 7 or 15 Hz caused also a significant release of dopamine metabolites. After pretreatment with reserpine, the release of dopamine evoked by stimulation at 15 Hz was abolished, whereas the evoked release of the metabolites was only reduced by about 55%. After MFMD, the evoked release of dopamine decreased by a percentage similar to that of dopamine tissue content, but the reduction of the evoked release of metabolites was more pronounced. In conclusion, the spontaneous release of dopamine metabolites from the dopaminergic nerve endings in the NIL largely reflects the catabolism of newly synthesized dopamine.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3553965     DOI: 10.1007/BF00165030

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  15 in total

1.  Monoamine metabolites: their relationship and lack of relationship to monoaminergic neuronal activity.

Authors:  J W Commissiong
Journal:  Biochem Pharmacol       Date:  1985-04-15       Impact factor: 5.858

2.  Histochemical demonstration of transmitter release from noradrenaline, dopamine and 5-hydroxytryptamine nerve terminals in field stimulated rat brain slices.

Authors:  L O Farnebo
Journal:  Z Zellforsch Mikrosk Anat       Date:  1971

3.  The organization of tubero-hypophyseal and reticulo-infundibular catecholamine neuron systems in the rat brain.

Authors:  A Björklund; R Y Moore; A Nobin; U Stenevi
Journal:  Brain Res       Date:  1973-03-15       Impact factor: 3.252

4.  Selective inhibitors of biosynthesis of aminergic neurotransmitters.

Authors:  J Kollonitsch; L M Perkins; A A Patchett; G A Doldouras; S Marburg; D E Duggan; A L Maycock; S D Aster
Journal:  Nature       Date:  1978-08-31       Impact factor: 49.962

5.  Dopaminergic modulation of evoked vasopressin release from the isolated neurohypophysis of the rat. Possible involvement of endogenous opioids.

Authors:  K Racké; H Ritzel; B Trapp; E Muscholl
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-04       Impact factor: 3.000

6.  Release of endogenous dopamine from rat isolated striatum: effect of clorgyline and (-)-deprenyl.

Authors:  L G Hársing; E S Vizi
Journal:  Br J Pharmacol       Date:  1984-11       Impact factor: 8.739

7.  Effect of neuroleptic drugs on striatal dopamine release and metabolism in the awake rat studied by intracerebral dialysis.

Authors:  T Zetterström; T Sharp; U Ungerstedt
Journal:  Eur J Pharmacol       Date:  1984-10-30       Impact factor: 4.432

8.  Release of endogenous 3,4-dihydroxyphenylethylamine and its metabolites from the isolated neurointermediate lobe of the rat pituitary gland. Effects of electrical stimulation and of inhibition of monoamine oxidase and reuptake.

Authors:  K Racké; E Muscholl
Journal:  J Neurochem       Date:  1986-03       Impact factor: 5.372

9.  Evidence for autoreceptor modulation of endogenous dopamine release from rabbit caudate nucleus in vitro.

Authors:  E M Parker; L X Cubeddu
Journal:  J Pharmacol Exp Ther       Date:  1985-02       Impact factor: 4.030

10.  Differences between the release of radiolabelled and endogenous dopamine from superfused rat brain slices: effects of depolarizing stimuli, amphetamine and synthesis inhibition.

Authors:  H Herdon; J Strupish; S R Nahorski
Journal:  Brain Res       Date:  1985-12-02       Impact factor: 3.252

View more
  2 in total

1.  Presynaptic regulation of the electrically evoked release of endogenous dopamine from the isolated neurointermediate lobe or isolated neural lobe of the rat pituitary gland in vitro.

Authors:  K Racké; A Grosshans; S Sirrenberg; K Ziegler
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-05       Impact factor: 3.000

2.  Lack of autoreceptor mediated regulation of the spontaneous dopamine turnover in the isolated neurointermediate lobe of the rat pituitary gland in vitro.

Authors:  K Racké; B Hering; K Ziegler
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-03       Impact factor: 3.000

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.